Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chen, N. Articles by Cheng, Q. Search for Related Content PubMed PubMed Citation Articles by Chen, N. Articles by Cheng, Q.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2008, p. 345-347, Vol. 52, No. 1
0066-4804/08/$08.00+0     doi:10.1128/AAC.00711-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

No Genetic Bottleneck in Plasmodium falciparum Wild-Type Pfcrt Alleles Reemerging in Hainan Island, China, following High-Level Chloroquine Resistance

Nanhua Chen,¹ Qi Gao,² Shanqing Wang,³ Guangze Wang,³ Michelle Gatton,⁴ and Qin Cheng^1,4*

Department of Drug Resistance and Diagnostics, Australian Army Malaria Institute, Enoggera, Queensland, Australia,¹ Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, People's Republic of China,² Hainan Provincial Center for Disease Control and Prevention, Haikou, Hainan, People's Republic of China,³ Malaria Drug Resistance and Diagnostics, Queensland Institute of Medical Research, Brisbane, Queensland, Australia⁴

Received 31 May 2007/ Returned for modification 27 August 2007/ Accepted 16 October 2007

Top ABSTRACT TEXT REFERENCES

 
Chloroquine-resistant Plasmodium falciparum was highly prevalent in Hainan, China, in the 1970s. Twenty-five years after cessation of chloroquine therapy, the prevalence of P. falciparum wild-type Pfcrt alleles has risen to 36% (95% confidence interval, 22.1 to 52.4%). The diverse origins of wild-type alleles indicate that there was no genetic bottleneck caused by high chloroquine resistance.

Top ABSTRACT TEXT REFERENCES

 
Chloroquine-resistant (CQR) Plasmodium falciparum became highly prevalent in Hainan Island, China, in the late 1970s, with 84% of clinical cases and 98% of samples tested for in vitro susceptibility being classified as CQR (6). In 1979, CQ was replaced by piperaquine as the first-line therapy for falciparum malaria (6). Since then, the occurrence of CQR P. falciparum has declined progressively (6), and the prevalence of the Pfcrt 76T mutation decreased from 90% in 1978 to 53 to 81% in 2001 (8). This rate of decline in prevalence of the 76T mutation is much lower than that reported for Malawi, where the prevalence of mutant Pfcrt alleles decreased from 85% in 1992 to 13% in 2000 (5). Several possible causes for the slow reversal of CQR in Hainan have been proposed, such as incomplete withdrawal of CQ and possible cross-selection by piperaquine (8). However, the genetic diversity of returning CQ-sensitive (CQS) parasites has not been examined. Any genetic bottleneck caused by the dominance of mutant Pfcrt alleles that reduces the diversity of the returning CQS parasites could impact parasite fitness and malaria epidemiology. Furthermore, the allelic type of CQR Pfcrt in Hainan has not been elucidated. In this study, we performed detailed molecular epidemiological investigations to define the allelic types of returning CQS parasites on the island as well as the allelic types of mutant Pfcrt and their origins. The results assist in understanding the mechanism and process of reversal of CQR after the cessation of CQ usage.

Fifty-one P. falciparum samples were collected from two areas in Hainan Island, China, between 2002 and 2004, including Wuzhishan City, a mountainous area central to the island (1.58% annual parasite incidence rate), and Qionghai City, an eastern hill area (0.17% annual parasite incidence rate). Ethics approval for the study was granted by the WHO Western Pacific Regional Office [(WP)WVP/ICP/MVP/1.4/001]. Parasite genomic DNA was extracted using a QIAamp DNA mini kit (Qiagen) following the manufacturer's instructions. Genotyping of msp1 and msp2 (7) indicated that 13.7% (7/51 samples) of samples had multiple-clone P. falciparum infections, with the remaining samples being clonal. Only the 44 clonal samples were analyzed further. DNA fragments of Pfcrt with reported mutations (2, 4) were amplified and sequenced. Five microsatellite (MS) markers flanking Pfcrt were also analyzed, including B5M77 (–20 kb), 2E10 (–5 kb), PE12A (+6 kb), 2H4 (+22 kb), and PE14F (+106 kb) (3, 10).

The combined msp1/msp2 genotyping revealed 31 different genotypes (Table 1). The addition of MS typing to the msp1/msp2 genotyping provided further resolution, distinguishing 41 different genotypes in the 44 samples, indicating the diverse genetic backgrounds of the parasites. Of the 44 isolates examined, 28 (64%; 95% confidence interval, 47.5 to 77.8%) had mutant Pfcrt genes (Table 1) with the same Pfcrt allelic type, i.e., the E1a type (9) commonly reported for Southeast Asia and Africa. The majority of the Pfcrt mutant isolates (27/28 isolates) had identical MS marker sizes for at least four of the five markers, and these were the same as those flanking the E1 Pfcrt allelic type (Table 1). The 28 mutant Pfcrt isolates had 21 different msp1/msp2 haplotypes. These results demonstrate that the mutant Pfcrt alleles in P. falciparum isolates collected from the two locations in Hainan share a common ancestry with Southeast Asian CQR parasites and that there has been little recombination around Pfcrt, while other antigen-encoding genes differ. CQR in Hainan was first reported in 1974, several years after CQR was reported in Southeast Asia. It is highly likely that CQR parasites were introduced to Hainan from Southeast Asia, given the close proximity of Hainan Island to Southeast Asia. CQR introduction to Hainan probably occurred in the late 1960s or early 1970s as part of the CQ selective sweep that spread across Southeast Asia and Africa (10).

View this table: [in this window] [in a new window]

TABLE 1. Pfcrt allelic types and polymorphisms in MS markers flanking Pfcrt in P. falciparum samples collected from Hainan, China, compared to those in samples from Southeast Asia

Sixteen isolates (36%; 95% confidence interval, 22.1 to 52.4%) were identified as having wild-type Pfcrt alleles, with no mutation in any examined fragment of Pfcrt (Table 1), and are thus susceptible to CQ. The lack of any mutation in the eight key codons identified in all mutant Pfcrt alleles suggests that the reduction in the prevalence of CQR parasites on Hainan Island is due to a resurgence of parasites with wild-type Pfcrt, not to back mutation of CQR parasites. In contrast to CQR isolates, the wild-type Pfcrt-carrying isolates showed highly diverse patterns of MS marker sizes flanking Pfcrt; 12 different MS patterns were identified in 16 wild-type Pfcrt isolates, with no apparent dominance of any pattern (Table 1). They also showed diversity in other genetic regions, with 15 different msp1/msp2 haplotypes, 5 of which were observed in Pfcrt mutant isolates. The results suggest that CQS parasites on the island have diverse origins and did not expand from one or a few clonal CQS populations. Therefore, despite the prevalence of mutant Pfcrt, nearly reaching fixation under CQ selection pressure, the number of CQS isolates did not become low enough to create a genetic bottleneck in the CQS parasite population.

The prevalence of wild-type Pfcrt alleles in our P. falciparum samples collected from central and eastern areas of Hainan Island is comparable to that previously reported by Wang et al. (8) for samples collected mostly from southern areas of the same island. Thus, it appears that wild-type CQS Pfcrt alleles are returning across the entire island. However, their frequency is still lower than that of the mutant CQR Pfcrt alleles 25 years after cessation of CQ therapy for falciparum malaria. Many factors may have contributed to the slow return of CQS parasites to Hainan Island, and our study suggests that a genetic bottleneck of CQS parasites is unlikely to be one of them. The CQR Pfcrt allelic type identified on the island matches the allele which is dominant in Africa, suggesting that the difference in CQS reemergence rates between Hainan and Malawi is not due to significant differences in the fitness of CQR parasites. There are two possible explanations for the observed difference in CQS reemergence rates. The first relates to the use of CQ for the treatment of vivax malaria. Since both Plasmodium species are present in Hainan, it is likely that some falciparum cases or mixed-species infections are diagnosed as vivax malaria and consequently treated with CQ. This would maintain some level of selection, but the full extent is difficult to ascertain. Alternatively, the use of piperaquine, a structurally similar compound to CQ, may also maintain some selection pressure, as there is evidence of weak cross-resistance between the two drugs (1). Although both factors may have contributed to the slow return of CQS parasites, it is more likely the result of continued CQ use. Importantly, the CQS parasites that are returning to the region retain diverse genetic backgrounds, which has implications for further control efforts.

 
The sample collection was funded by a WHO grant [(WP)WVP/ICP/MVP/1.4/001], and the experimental work was partially funded by an NIH grant (5RO1AI047500-06).

The opinions expressed herein are those of the authors and do not necessarily reflect those of the Defense Health Service or any extant policy of Department of Defense, Australia.

We thank Dennis Shanks for reviewing the manuscript.

 
* Corresponding author. Mailing address: Department of Drug Resistance and Diagnostics, Australian Army Malaria Institute, Weary Dunlop Drive, Gallipoli Barracks, Enoggera, Queensland 4051, Australia. Phone: 61-7-33324834. Fax: 61-7-33324800. E-mail: qin.cheng{at}defence.gov.au

Published ahead of print on 22 October 2007.

Top ABSTRACT TEXT REFERENCES

 

1
1. Basco, L. K., and P. Ringwald. 2003. In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon. Antimicrob. Agents Chemother. 47:1391-1394.[Abstract/Free Full Text]
2
2. Chen, N., D. E. Kyle, C. Pasay, E. V. Fowler, J. Baker, J. M. Peters, and Q. Cheng. 2003. Pfcrt allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines. Antimicrob. Agents Chemother. 47:3500-3505.[Abstract/Free Full Text]
3
3. Chen, N., D. W. Wilson, C. Pasay, D. Bell, L. B. Martin, D. Kyle, and Q. Cheng. 2005. Origin and dissemination of chloroquine-resistant Plasmodium falciparum with mutant Pfcrt alleles in the Philippines. Antimicrob. Agents Chemother. 49:2102-2105.[Abstract/Free Full Text]
4
4. Fidock, D. A., T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov, M. T. Ferdig, L. M. Ursos, A. B. Sidhu, B. Naude, K. W. Deitsch, X. Z. Su, J. C. Wootton, P. D. Roepe, and T. E. Wellems. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.[CrossRef][Medline]
5
5. Kublin, J. G., J. F. Cortese, E. M. Njunju, R. A. Mukadam, J. J. Wirima, P. N. Kazembe, A. A. Djimde, B. Kouriba, T. E. Taylor, and C. V. Plowe. 2003. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187:1870-1875.[CrossRef][Medline]
6
6. Liu, D. Q., R. J. Liu, D. X. Ren, D. Q. Gao, C. Y. Zhang, C. P. Qui, X. Z. Cai, C. F. Ling, A. H. Song, and X. Tang. 1995. Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China. Bull. W. H. O. 73:483-486.[Medline]
7
7. Ranford, C. L., J. Taylor, T. Umasunthar, L. H. Taylor, H. A. Babiker, B. Lell, O. J. Schmidt, L. G. Lehman, D. Walliker, and P. G. Kremsner. 1997. Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans. R. Soc. Trop. Med. Hyg. 91:719-724.[CrossRef][Medline]
8
8. Wang, X., J. Mu, G. Li, P. Chen, X. Guo, L. Fu, L. Chen, X. Su, and T. E. Wellems. 2005. Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China. Am. J. Trop. Med. Hyg. 72:410-414.[Abstract/Free Full Text]
9
9. Wellems, T. E., and C. V. Plowe. 2001. Chloroquine-resistant malaria. J. Infect. Dis. 184:770-776.[CrossRef][Medline]
10
10. Wootton, J. C., X. Feng, M. T. Ferdig, R. A. Cooper, J. Mu, D. I. Baruch, A. J. Magill, and X. Z. Su. 2002. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418:320-323.[CrossRef][Medline]

---

Antimicrobial Agents and Chemotherapy, January 2008, p. 345-347, Vol. 52, No. 1
0066-4804/08/$08.00+0     doi:10.1128/AAC.00711-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chen, N. Articles by Cheng, Q. Search for Related Content PubMed PubMed Citation Articles by Chen, N. Articles by Cheng, Q.